- Home
- TCMD vs VALN Comparison
TCMD vs VALN Comparison
Compare TCMD & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCMD
- VALN
- Stock Information
- Founded
- TCMD 1995
- VALN 2012
- Country
- TCMD United States
- VALN France
- Employees
- TCMD N/A
- VALN N/A
- Industry
- TCMD Medical/Dental Instruments
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TCMD Health Care
- VALN Health Care
- Exchange
- TCMD Nasdaq
- VALN Nasdaq
- Market Cap
- TCMD 427.6M
- VALN 354.8M
- IPO Year
- TCMD 2016
- VALN 2021
- Fundamental
- Price
- TCMD $17.54
- VALN $5.65
- Analyst Decision
- TCMD Hold
- VALN Strong Buy
- Analyst Count
- TCMD 1
- VALN 2
- Target Price
- TCMD N/A
- VALN $17.50
- AVG Volume (30 Days)
- TCMD 199.9K
- VALN 50.9K
- Earning Date
- TCMD 02-18-2025
- VALN 03-20-2025
- Dividend Yield
- TCMD N/A
- VALN N/A
- EPS Growth
- TCMD N/A
- VALN N/A
- EPS
- TCMD 0.65
- VALN N/A
- Revenue
- TCMD $285,051,000.00
- VALN $176,817,979.00
- Revenue This Year
- TCMD $8.83
- VALN $24.66
- Revenue Next Year
- TCMD $9.86
- VALN $9.67
- P/E Ratio
- TCMD $27.15
- VALN N/A
- Revenue Growth
- TCMD 5.31
- VALN N/A
- 52 Week Low
- TCMD $11.12
- VALN $3.62
- 52 Week High
- TCMD $21.10
- VALN $9.50
- Technical
- Relative Strength Index (RSI)
- TCMD 50.42
- VALN 64.26
- Support Level
- TCMD $17.09
- VALN $4.71
- Resistance Level
- TCMD $18.51
- VALN $5.82
- Average True Range (ATR)
- TCMD 0.53
- VALN 0.24
- MACD
- TCMD -0.01
- VALN 0.10
- Stochastic Oscillator
- TCMD 31.88
- VALN 72.22
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.